Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Home
Profiles
Research units
Research output
Prizes
Search by expertise, name or affiliation
Combining flagellin and human β-defensin-3 to combat bacterial infections
Ofra Sabag
,
Haya Lorberboum-Galski
*
*
Corresponding author for this work
Department of Developmental Biology and Cancer Research
Department of Biochemistry and Molecular Biology
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Combining flagellin and human β-defensin-3 to combat bacterial infections'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bacterial Infection
100%
Flagellin
100%
Human Defensins
100%
Fusion Protein
22%
Two-component
22%
F Protein
22%
Protective Effect
11%
Healthy Donors
11%
Escherichia Coli
11%
Innovative Approach
11%
Therapeutic Use
11%
In Vitro Activity
11%
Immune System
11%
Antibiotic Use
11%
Th1 Response
11%
MRNA Level
11%
Mechanism of Action
11%
Antibacterial Activity
11%
Bacterial Strains
11%
Interleukin-8
11%
Defensin
11%
Salmonella
11%
Bacterial Proteins
11%
Pathogenic Escherichia Coli
11%
Antibacterial Peptide
11%
Interleukin-12 (IL-12)
11%
CD4+ T Cells
11%
Lethal Infection
11%
Escherichia Coli Bacteria
11%
Partial Protection
11%
Resistance to Antibiotics
11%
Human Mortality
11%
Human Morbidity
11%
Pharmacology, Toxicology and Pharmaceutical Science
Bacterial Infection
100%
Flagellin
100%
Defensin
100%
Receptor
22%
Antibiotics
22%
Escherichia coli
22%
Chimeric Protein
22%
Disease
11%
Cytokine
11%
Antibacterial Activity
11%
Salmonella
11%
Polypeptide Antibiotic Agent
11%
Pathogenic Escherichia Coli
11%
Therapeutic Use
11%
Bacterial Protein
11%
Messenger RNA
11%
Immunology and Microbiology
Flagellin
100%
Defensin
100%
Escherichia coli
22%
Secretion (Process)
11%
Antibacterial Activity
11%
Immune System
11%
Bacterial Strain
11%
Target Cell
11%
Pathogenic Escherichia Coli
11%
Antimicrobial Peptides
11%
T-Helper Cell
11%
Salmonella
11%
Cytokine Response
11%
Interleukin 8
11%